ProFound Therapeutics is pioneering the discovery of a vastly expanded human proteome and using its newfound insights to unlock a universe of potential new medicines. The company’s ProFoundry Platform uses state-of-the-art protein detection technologies to systematically identify and validate proteins and dissect their therapeutic potential. The result is an ever-expanding database of tens of thousands of novel proteins, including their connectivity, functionality, and roles in health and disease. ProFound Therapeutics was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.
Location: United States
Employees: 11-50
Total raised: $35M
Founded date: 2022
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.08.2026 | - | $35M | Bill &... |
Mentions in press and media 3
| Date | Title | Description |
| 27.08.2026 | ProFound Therapeutics Receives $35M Investment | ProFound Therapeutics, a Cambridge, MA-based developer of medicines harnessing the expanded human proteome, received an investment of up to $35M from the Gates Foundation, including an initial investment of $20M. The company intends to use ... |
| 27.05.2022 | Biotech Start-Up Finds Overlooked Proteins That Could Cure Diseases | If you were under the impression that our genome had about 20,000 genes, each a recipe for a different protein, you’re not alone. The Human Genome Project celebrated the first mapping of those 20,000 genes two decades ago. But a new start-u... |
| - | ProFound Therapeutics | “ProFound Therapeutics” |